The neurovascular devices market was valued at USD 7.28 billion in 2024 and is projected to reach USD 7.70 billion in 2025 and USD 12.84 billion by 2034, expanding at a CAGR of 5.9% during the forecast period 2025–2034. Growth is underpinned by the rising prevalence of ischemic stroke and intracranial aneurysms, expanding stroke care infrastructure, and rapid innovation in device design. This analysis highlights the fastest-growing segments and technologies for B2B stakeholders.

Neurothrombectomy Devices Lead Growth

The neurothrombectomy devices segment is projected to grow at the fastest CAGR among device types, driven by increasing use in acute ischemic stroke management. Stent retrievers and aspiration catheters restore blood flow by mechanically removing clots within the treatment window, significantly improving outcomes. Growth is further supported by updated clinical guidelines recommending mechanical thrombectomy as the standard of care for eligible patients, while expanding stroke care infrastructure and greater availability of comprehensive stroke centers are fueling rapid adoption.

Cerebral Aneurysms Segment Accelerates

By application, the cerebral aneurysms segment is projected to grow at the fastest CAGR, owing to rising adoption of flow diverters and embolic coils. In July 2025, Q'Apel Medical received FDA clearance for its Zebra Neurovascular Access System, now preparing for a full U.S. launch in 6 Fr and 7 Fr sizes, with a laser-cut striped design offering flexibility and support in complex anatomy. Minimally invasive endovascular techniques are increasingly preferred over open surgical clipping for shorter recovery and lower complication risk, and advanced imaging is enabling earlier detection.

Browse Insights:

https://www.polarismarketresearch.com/industry-analysis/neurovascular-device-market

Specialty Clinics Post the Fastest End-User Growth

Hospitals dominated by end user in 2024, thanks to advanced infrastructure, specialized neurointerventional teams, and handling of the majority of emergency cases. Specialty clinics, however, are projected to grow at the fastest CAGR, owing to demand for focused, personalized care for conditions such as aneurysms, arteriovenous malformations, and stroke rehabilitation, with shorter wait times and more individualized attention. Advances in portable imaging and minimally invasive devices are enabling complex procedures outside traditional hospital settings.

AI-Assisted Imaging and Robotic Navigation

The integration of AI-assisted imaging and robotic navigation systems creates opportunities to improve accuracy and efficiency in neurovascular procedures. Imaging and navigation systems already enable accurate placement and control during complex interventions. In June 2025, Philips launched SmartCT in Europe after CE marking, enabling real-time 3D imaging for faster stroke diagnosis and treatment. Rapid innovation in device design and procedure techniques is expected to enhance treatment precision, safety, and accessibility.

Asia Pacific and China Opportunity

Asia Pacific is projected to grow at the fastest regional CAGR, as rising accessibility in China, India, and Japan and government initiatives such as specialized stroke units and catheterization labs increase procedural capacity. In China, average life expectancy has risen to 78.6 years and the population aged 60 and above is projected to exceed 400 million by 2035. Rapid expansion of tertiary hospitals with modern catheterization labs, along with collaborations with global device makers, is widening access to minimally invasive neurovascular interventions.

Competitive Landscape of the Neurovascular Devices Market

The neurovascular devices  is moderately competitive, with leading manufacturers developing advanced minimally invasive solutions. Companies are enhancing portfolios with improved thrombectomy devices, high-precision embolization systems, and next-generation flow diverters, and strategic collaborations among device companies, academic institutions, and healthcare providers are driving innovation. Key players include Medtronic plc, Stryker Corporation, Penumbra, Inc., Terumo Corporation, MicroPort Scientific Corporation, Balt Group SAS, Kaneka Corporation, Johnson & Johnson, Acandis GmbH, phenox GmbH, Rapid Medical Ltd., and Asahi Intecc Co., Ltd. Embolization devices dominated by device type in 2024 and ischemic stroke dominated by application, reflecting extensive use in aneurysm occlusion and urgent stroke intervention. High device costs and limited availability of skilled neurointerventional specialists hinder adoption.

More Trending Latest Reports By Polaris Market Research:

quick-service-restaurants-qsr-market

data-center-switch-market

exosomes-market

nonlinear-optical-crystals-market

aerogel-market

dupixent-market

fire-resistant-fabrics-market

us-c4isr-market

fuel-additives-market